LPL and diabetic cardiomyopathy: Several lines of transgenic mice, especially those overexpressing long-chain acyl-CoA synthetase in cardiomyocytes [25], fatty acid transport protein 1 [97], lipoprotein lipase (LpL) [98], or PPARα [99] using the α-myosin heavy chain promoter, exhibited similar phenotypes to diabetic cardiomyopathy.